
Mark Cuban doesn’t believe in following your passions | ReThinking w/ Adam Grant
The TED Interview
Cost Plus - Are You Going to Compete or What?
Cost plus is a new way to make drugs more affordable for patients. The move has been met with criticism from both sides of the drug industry. Pharmacy benefit managers and insurance companies are among those who have opposed it, says Dr Peter Rieckhoff. "We're the manufacturers best friend," he adds.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.